Privia Health Group, Inc. (PRVA): EBITDA

Operating income plus depreciation and amortization for the same annual period and currency, computed by TickerFacts from the filed figures. Not the company's adjusted EBITDA; a year without both inputs is left out.

$44.14M
Year ended 2025-12-31
$56.94M
Trailing 12 months to 2026-06-30
+10.1%
5-year compound annual growth
2019-12-31: $17.49M2020-12-31: $27.22M2021-12-31: -$214.97M2022-12-31: -$14.55M2023-12-31: $27.18M2024-12-31: $24.25M2025-12-31: $44.14M$44.14M
2019-12-31 EBITDA (USD) 2025-12-31
Period endedEBITDAChange YoYSource filing
2025-12-31$44.14M+82.0%2026-02-27, From 2025-01-01
2024-12-31$24.25M-10.8%2026-02-27, From 2024-01-01
2023-12-31$27.18Mn/m2026-02-27, From 2023-01-01
2022-12-31-$14.55Mn/m2025-02-27, From 2022-01-01
2021-12-31-$214.97Mn/m2024-02-27, From 2021-01-01
2020-12-31$27.22M+55.7%2023-03-01, From 2020-01-01
2019-12-31$17.49Mn/a2022-03-25, From 2019-01-01

EBITDA at similar companies

Companies with the same SEC industry code (Services-Health Services), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedEBITDAChange YoY
Privia Health Group, Inc. (PRVA)2025-12-31$44.14M+82.0%
P3 Health Partners Inc. (PIII)2025-12-31-$186.14Mn/m
LifeStance Health Group, Inc. (LFST)2025-12-31$65.77M+625.6%
InnovAge Holding Corp. (INNV)2026-06-30$23.76Mn/m
Pennant Group, Inc. (PNTG)2025-12-31$60.42M+36.6%
U S Physical Therapy Inc (USPH)2025-12-31$109.07M+33.5%
GeneDx Holdings Corp. (WGS)2025-12-31-$3.48Mn/m
DocGo Inc. (DCGO)2025-12-31-$162.37Mn/m
Omada Health, Inc. (OMDA)2025-12-31-$6.48Mn/m

Compare PRVA, PIII, LFST, INNV side by side · Screen every company in Services-Health Services ↗